Restoration of the striatal circuitry: From developmental aspects towards clinical applications

Frontiers in Cellular Neuroscience

Volumn , Issue MARCH, 2012, Pages

  Pauly, Marie Christin ^a   Piroth, Tobias ^a   Döbrössy, Máté ^a   Nikkhah, Guido ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Development; Ganglionic eminence; Huntington's disease; Striatum; Transplantation

Indexed keywords

CYCLOSPORIN A; DOUBLECORTIN; KI 67 ANTIGEN; PHOSPHOPROTEIN DARPP 32; TRANSCRIPTION FACTOR SOX2;

ANIMAL BEHAVIOR; ANIMAL HOUSING; BASAL GANGLION; BRAIN DEGENERATION; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL STRUCTURE; CLINICAL TRIAL (TOPIC); COGNITION; CONVALESCENCE; DISEASE MODEL; EMBRYONIC STEM CELL; ENVIRONMENTAL FACTOR; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; HUNTINGTON CHOREA; MEDIAN EMINENCE; MEDICAL RESEARCH; MOLECULAR MECHANICS; MOTOR PERFORMANCE; MULTICENTER STUDY (TOPIC); NERVE CELL; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; REVIEW; SOMATIC CELL; STEM CELL TRANSPLANTATION; STRIATE CORTEX; TRAINING; TREATMENT OUTCOME;

EID: 84859339953     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2012.00016     Document Type: Review

References (110)

1. Aubry, L., A Bugi, N Lefort, F Rousseau, M Peschanski, and A L Perrier. 2008. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proceedings of the National Academy of Sciences of the United States of America 105 (43) (October 28): 16707-16712. doi:10.1073/pnas.0808488105.
2. Bachoud-Lévi, A C, P Rémy, J P Nguyen, P Brugières, J P Lefaucheur, C Bourdet, S Baudic, et al. 2000. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 356 (9246) (December 9): 1975-1979.
3. Bachoud-Lévi, A C. 2009. Neural grafts in Huntington's disease: viability after 10 years. Lancet Neurology 8 (11) (November): 979-981. doi:10.1016/S1474-4422(09)70278-9.
4. Bachoud-Lévi, A C, V Gaura, P Brugières, J P Lefaucheur, M F Boissé, P Maison, S Baudic, et al. 2006. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurology 5 (4) (April): 303-309. doi:10.1016/S1474-4422(06)70381-7.
5. Baydyuk, M, T Russell, G Y Liao, K Zang, J J An, L French Reichardt, and B Xu. 2011. TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons. Proceedings of the National Academy of Sciences of the United States of America 108 (4) (January 25): 1669-1674. doi:10.1073/pnas.1004744108.
6. Beal, M F. 1998. Mitochondrial dysfunction in neurodegenerative diseases. Biochimica Et Biophysica Acta 1366 (1-2) (August 10): 211-223.
7. Beal, M F, E Brouillet, B G Jenkins, R J Ferrante, N W Kowall, J M Miller, E Storey, R Srivastava, B R Rosen, and B T Hyman. 1993. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 13 (10) (October): 4181-4192.
8. Beal, M F, R J Ferrante, K J Swartz, and N W Kowall. 1991. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 11 (6) (June): 1649-1659.
9. Beal, M F, N W Kowall, D W Ellison, M F Mazurek, K J Swartz, and J B Martin. 1986. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321 (6066) (May 8): 168-171. doi:10.1038/321168a0.
10. Beal, M F, N W Kowall, K J Swartz, R J Ferrante, and J B Martin. 1989.Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse (New York, N.Y.) 3 (1): 38-47. doi:10.1002/syn.890030106.
11. Beal, M F. 1992. Role of excitotoxicity in human neurological disease. Current Opinion in Neurobiology 2 (5) (October): 657-662. doi:doi: DOI: 10.1016/0959-4388(92)90035-J.
12. Brasted, P J, C Watts, T W Robbins, and S B Dunnett. 1999. Associative plasticity in striatal transplants. Proceedings of the National Academy of Sciences of the United States of America 96 (18) (August 31): 10524-10529.
13. Brasted, P J, C Watts, E M Torres, T W Robbins, and S B Dunnett. 1999. Behavioural recovery following striatal transplantation: effects of postoperative training and P-zone volume. Experimental Brain Research. Experimentelle Hirnforschung. Expérimentation Cérébrale 128 (4) (October): 535-538.
14. Brouillet, E, B G Jenkins, B T Hyman, R J Ferrante, N W Kowall, R Srivastava, D S Roy, B R Rosen, and M F Beal. 1993. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. Journal of Neurochemistry 60 (1) (January): 356-359.
15. Brown, V J, and T W Robbins. 1989. Elementary processes of response selection mediated by distinct regions of the striatum. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 9 (11) (November): 3760-3765.
16. Caiazzo, M, M T Dell'Anno, E Dvoretskova, D Lazarevic, S Taverna, D Leo, T D Sotnikova, et al. 2011. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 476 (7359) (August 11): 224-227. doi:10.1038/nature10284.
17. Capetian, P, R Knoth, J Maciaczyk, G Pantazis, M Ditter, L Bokla, G B Landwehrmeyer, B Volk, and G Nikkhah. 2009. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience 160 (3) (May 19): 661-675. doi:10.1016/j.neuroscience.2009.02.035.
18. Capetian, P, M Döbrössy, C Winkler, M Prinz, and G Nikkhah. 2011. To be or not to be accepted: the role of immunogenicity of neural stem cells following transplantation into the brain in animal and human studies. Seminars in Immunopathology 33 (6) (November): 619-626. doi:10.1007/s00281-011-0272-x.
19. Cenci, M A, I Q Whishaw, and T Schallert. 2002. Animal models of neurological deficits: how relevant is the rat? Nature Reviews. Neuroscience 3 (7) (July): 574-579. doi:10.1038/nrn877.
20. Choi, D W. 1987. Ionic dependence of glutamate neurotoxicity. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 7 (2) (February): 369-379.
21. Cicchetti, F, S Saporta, R A Hauser, M Parent, M Saint-Pierre, P R Sanberg, X J Li, et al. 2009. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proceedings of the National Academy of Sciences of the United States of America 106 (30) (July 28): 12483-12488. doi:10.1073/pnas.0904239106.
22. Clarke, D J, and S B Dunnett. 1993. Synaptic relationships between cortical and dopaminergic inputs and intrinsic GABAergic systems within intrastriatal striatal grafts. Journal of Chemical Neuroanatomy 6 (3) (June): 147-158.
23. Coffey, JT, and R Schwarz. 1976. Lesions of striatal neurones with kainic acid provides a model for Huntington's chorea 263: 244-246.
24. Coffey, P J, R D Lund, and J N Rawlins. 1989. Retinal transplant-mediated learning in a conditioned suppression task in rats. Proceedings of the National Academy of Sciences of the United States of America 86 (18) (September): 7248-7249.
25. Corbin, J G, M Rutlin, N Gaiano, and G Fishell. 2003. Combinatorial function of the homeodomain proteins Nkx2.1 and Gsh2 in ventral telencephalic patterning. Development (Cambridge, England) 130 (20) (October): 4895-4906. doi:10.1242/dev.00717.
26. Coyle, J T, and R Schwarcz. 1976. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 263 (5574) (September 16): 244-246.
27. Crook, Zachary R, and David Housman. 2011. Huntington's disease: can mice lead the way to treatment? Neuron 69 (3) (February 10): 423-435. doi:10.1016/j.neuron.2010.12.035.
28. Divac, I, H J Markowitsch, and M Pritzel. 1978. Behavioral and anatomical consequences of small intrastriatal injections of kainic acid in the rat. Brain Research 151 (3) (August 11): 523-532.
29. Döbrössy, M D, and S B Dunnett. 1998. Striatal grafts alleviate deficits in response execution in a lateralised reaction time task. Brain Research Bulletin 47 (6) (December): 585-593.
30. Döbrössy, M D, and S B Dunnett. 2001. The influence of environment and experience on neural grafts. Nature Reviews. Neuroscience 2 (12) (December): 871-879. doi:10.1038/35104055.
31. Döbrössy, M D, and S B Dunnett. 2005. Training specificity, graft development and graft-mediated functional recovery in a rodent model of Huntington's disease. Neuroscience 132 (3): 543-552. doi:10.1016/j.neuroscience.2005.01.016.
32. Döbrössy, M D, and S B Dunnett. 2003. Motor training effects on recovery of function after striatal lesions and striatal grafts. Experimental Neurology 184 (1) (November): 274-284.
33. Döbrössy, M D, and S B Dunnett. 2006a. The effects of lateralized training on spontaneous forelimb preference, lesion deficits, and graft-mediated functional recovery after unilateral striatal lesions in rats. Experimental Neurology 199 (2) (June): 373-383. doi:10.1016/j.expneurol.2005.12.033.
34. Döbrössy, M D, and S B Dunnett. 2006b. Morphological and cellular changes within embryonic striatal grafts associated with enriched environment and involuntary exercise. The European Journal of Neuroscience 24 (11) (December): 3223-3233. doi:10.1111/j.1460-9568.2006.05182.x.
35. Döbrössy, M D, and S B Dunnett. 2007. The corridor task: striatal lesion effects and graft-mediated recovery in a model of Huntington's disease. Behavioural Brain Research 179 (2) (May 16): 326-330. doi:10.1016/j.bbr.2007.02.030.
36. Döbrössy, M D, and S B Dunnett. 2008. Environmental housing and duration of exposure affect striatal graft morphology in a rodent model of Huntington's disease. Cell Transplantation 17 (10-11): 1125-1134.
37. Döbrössy, M, M Busse, T Piroth, A Rosser, S Dunnett, and G Nikkhah. 2010. Neurorehabilitation with neural transplantation. Neurorehabilitation and Neural Repair 24 (8) (October): 692-701. doi:10.1177/1545968310363586.
38. Dunnett, S B, O Isacson, D J Sirinathsinghji, D J Clarke, and A Björklund. 1988. Striatal grafts in rats with unilateral neostriatal lesions--III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 24 (3) (March): 813-820.
39. Dunnett, S B, and A E Rosser. 2011. Clinical translation of cell transplantation in the brain. Current Opinion in Organ Transplantation 16 (6) (December): 632-639. doi:10.1097/MOT.0b013e32834c2356.
40. Durieux, P F, S N Schiffmann, and A de Kerchove d'Exaerde. 2011. Targeting neuronal populations of the striatum. Frontiers in Neuroanatomy 5: 40. doi:10.3389/fnana.2011.00040.
41. Freeman, T B, F Cicchetti, R A Hauser, T W Deacon, X J Li, S M Hersch, G M Nauert, et al. 2000. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proceedings of the National Academy of Sciences of the United States of America 97 (25) (December 5): 13877-13882. doi:10.1073/pnas.97.25.13877.
42. Fricker, R A, L E Annett, E M Torres, and S B Dunnett. 1996. The placement of a striatal ibotenic acid lesion affects skilled forelimb use and the direction of drug-induced rotation. Brain Research Bulletin 41 (6): 409-416.
43. Fricker, R A, R A Barker, J W Fawcett, and S B Dunnett. 1996. A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplantation 5 (6) (December): 599-611.
44. Fricker, R A, E M Torres, and S B Dunnett. 1997. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. I. Morphological characteristics. Neuroscience 79 (3) (August): 695-710.
45. Fricker, R A, E M Torres, S P Hume, R Myers, J Opacka-Juffrey, S Ashworth, D J Brooks, and S B Dunnett. 1997. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 79 (3) (August): 711-721.
46. Gerfen, C R. 1989. The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science (New York, N.Y.) 246 (4928) (October 20): 385-388.
47. Gerfen, C R. 1992. The neostriatal mosaic: multiple levels of compartmental organization. Trends in Neurosciences 15 (4) (April): 133-139. doi:10.1016/0166-2236(92)90355-C.
48. Hamasaki, T, S Goto, S Nishikawa, and Y Ushio. 2003. Neuronal cell migration for the developmental formation of the mammalian striatum. Brain Research. Brain Research Reviews 41 (1) (January): 1-12.
49. Hauser, R A, S Furtado, C R Cimino, H Delgado, S Eichler, S Schwartz, D Scott, et al. 2002. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 58 (5) (March 12): 687-695.
50. Heng, M Y, P J Detloff, and R L Albin. 2008. Rodent genetic models of Huntington disease. Neurobiology of Disease 32 (1) (October): 1-9. doi:10.1016/j.nbd.2008.06.005.
51. Henshaw, R, B G Jenkins, J B Schulz, R J Ferrante, N W Kowall, B R Rosen, and M F Beal. 1994. Malonate produces striatal lesions by indirect NMDA receptor activation. Brain Research 647 (1) (May 30): 161-166.
52. Isacson, O, P Brundin, P A Kelly, F H Gage, and A Björklund. 1984. Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature 311 (5985) (October 4): 458-460.
53. Isacson, O, S B Dunnett, and A Björklund. 1986. Graft-induced behavioral recovery in an animal model of Huntington disease. Proceedings of the National Academy of Sciences of the United States of America 83 (8) (April): 2728-2732.
54. Jiang, Wei, Fabian Büchele, Anna Papazoglou, Máté Döbrössy, and Guido Nikkhah. 2010. Multi-tract microtransplantation increases the yield of DARPP-32 positive embryonic striatal cells in a rodent model of Huntington's disease. Cell Transplantation (December 22). doi:10.3727/096368910X547435. http://www.ncbi.nlm.nih.gov/pubmed/21176402.
55. Kawaguchi, Y. 1997. Neostriatal cell subtypes and their functional roles. Neuroscience Research 27 (1) (January): 1-8.
56. Kawaguchi, Y, C J Wilson, S J Augood, and P C Emson. 1995. Striatal interneurones: chemical, physiological and morphological characterization. Trends in Neurosciences 18 (12) (December): 527-535.
57. Keene, C D, J A Sonnen, P D Swanson, O Kopyov, J B Leverenz, T D Bird, and T J Montine. 2007. Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology 68 (24) (June 12): 2093-2098. doi:10.1212/01.wnl.0000264504.14301.f5.
58. Keene, C Dirk, Rubens C Chang, James B Leverenz, Oleg Kopyov, Susan Perlman, Robert F Hevner, Donald E Born, Thomas D Bird, and Thomas J Montine. 2009. A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions. Acta Neuropathologica 117 (3) (March): 329-338. doi:10.1007/s00401-008-0465-0.
59. Kopyov, O V, S Jacques, A Lieberman, C M Duma, and K S Eagle. 1998. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Experimental Neurology 149 (1) (January): 97-108. doi:10.1006/exnr.1997.6685.
60. Krushel, L A, G Fishell, and D van der Kooy. 1995. Pattern formation in the mammalian forebrain: striatal patch and matrix neurons intermix prior to compartment formation. The European Journal of Neuroscience 7 (6) (June 1): 1210-1219.
61. Krystkowiak, P, V Gaura, M Labalette, A Rialland, P Remy, M Peschanski, and A C Bachoud-Lévi. 2007. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PloS One 2 (1): e166. doi:10.1371/journal.pone.0000166.
62. Lau, A and M Tymianski. 2010. Glutamate receptors, neurotoxicity and neurodegeneration. Pflügers Archiv: European Journal of Physiology 460 (2) (July): 525-542. doi:10.1007/s00424-010-0809-1.
63. Lindvall, O, and A Björklund. 2011. Cell therapeutics in Parkinson's disease. Neurotherapeutics: The Journal of the American Society for Experimental Neuro Therapeutics 8 (4) (October): 539-548. doi:10.1007/s13311-011-0069-6.
64. Long, J E, I Cobos, G B Potter, and J L R Rubenstein. 2009. Dlx1&2 and Mash1 transcription factors control MGE and CGE patterning and differentiation through parallel and overlapping pathways. Cerebral Cortex (New York, N.Y.: 1991) 19 Suppl 1 (July): i96-106. doi:10.1093/cercor/bhp045.
65. Long, J E, C Swan, W S Liang, I Cobos, G B Potter, and J L R Rubenstein. 2009. Dlx1&2 and Mash1 transcription factors control striatal patterning and differentiation through parallel and overlapping pathways. The Journal of Comparative Neurology 512 (4) (February 1): 556-572. doi:10.1002/cne.21854.
66. Madrazo, I, R E Franco-Bourland, H Castrejon, C Cuevas, and F Ostrosky-Solis. 1995. Fetal striatal homotransplantation for Huntington's disease: first two case reports. Neurological Research 17 (4) (August): 312-315.
67. Marín, O, and J L Rubenstein. 2001. A long, remarkable journey: tangential migration in the telencephalon. Nature Reviews. Neuroscience 2 (11) (November): 780-790. doi:10.1038/35097509.
68. Marin, O, S A Anderson, and J L Rubenstein. 2000. Origin and molecular specification of striatal interneurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 20 (16) (August 15): 6063-6076.
69. Martynoga, B, H Morrison, D J Price, and J O Mason. 2005. Foxg1 is required for specification of ventral telencephalon and region-specific regulation of dorsal telencephalic precursor proliferation and apoptosis. Developmental Biology 283 (1) (July 1): 113-127. doi:10.1016/j.ydbio.2005.04.005.
70. Matamales, M, J Bertran-Gonzalez, L Salomon, B Degos, J M Deniau, E Valjent, D Hervé, and J A Girault. 2009. Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice. PloS One 4 (3): e4770. doi:10.1371/journal.pone.0004770.
71. Mayer, E., V. J. Brown, S. B. Dunnett, and T. W. Robbins. 1992. Striatal Graft-Associated Recovery of a Lesion-Induced Performance Deficit in the Rat Requires Learning to Use The Transplant. The European Journal of Neuroscience 4 (2): 119-126.
72. Mazzocchi-Jones, D, M D Döbrössy, and S B Dunnett. 2005. Striatal grafts and synaptic plasticity. In Basal Ganglia VIII (eds. Bolam, J.Paul; Ingham, Cali A.; Magill, Peter J.), 313-320. New York: Springer.
73. Mazzocchi-Jones, D, M D Döbrössy, and S Dunnett. 2011. Environmental Enrichment Facilitates Long-Term Potentiation in Embryonic Striatal Grafts. Neurorehabilitation and Neural Repair (accepted for publication).
74. Mazzocchi-Jones, D, M D Döbrössy, and S Dunnett. 2009. Embryonic striatal grafts restore bi-directional synaptic plasticity in a rodent model of Huntington's disease. European Journal of Neuroscience 30: 2134-2142.
75. McGeorge, A J, and R L Faull. 1989. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29 (3): 503-537.
76. Le Moine, C, and B Bloch. 1995. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. The Journal of Comparative Neurology 355 (3) (May 8): 418-426. doi:10.1002/cne.903550308.
77. Nicoleau, C, P Viegas, M Peschanski, and A L Perrier. 2011. Human Pluripotent Stem Cell Therapy for Huntington's Disease: Technical, Immunological, and Safety Challenges. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics (October 6). doi:10.1007/s13311-011-0079-4. http://www.ncbi.nlm.nih.gov/pubmed/21976138.
78. Nikkhah, G, C Rosenthal, G Falkenstein, A Roedter, A Papazoglou, and A Brandis. 2009. Microtransplantation of dopaminergic cell suspensions: further characterization and optimization of grafting parameters. Cell Transplantation 18 (2): 119-133.
79. Nóbrega-Pereira, S, N Kessaris, T Du, S Kimura, S A Anderson, and O Marín. 2008. Postmitotic Nkx2-1 controls the migration of telencephalic interneurons by direct repression of guidance receptors. Neuron 59 (5) (September 11): 733-745. doi:10.1016/j.neuron.2008.07.024.
80. Paek, H, G Gutin, and J M Hébert. 2009. FGF signaling is strictly required to maintain early telencephalic precursor cell survival. Development (Cambridge, England) 136 (14) (July): 2457-2465. doi:10.1242/dev.032656.
81. Passante, L, N Gaspard, M Degraeve, J Frisén, K Kullander, V De Maertelaer, and P Vanderhaeghen. 2008. Temporal regulation of ephrin/Eph signalling is required for the spatial patterning of the mammalian striatum. Development (Cambridge, England) 135 (19) (October): 3281-3290. doi:10.1242/dev.024778.
82. Pfisterer, U, J Wood, K Nihlberg, O Hallgren, L Bjermer, G Westergren-Thorsson, O Lindvall, and M Parmar. 2011. Efficient induction of functional neurons from adult human fibroblasts. Cell Cycle (Georgetown, Tex.) 10 (19) (October 1): 3311-3316. doi:10.4161/cc.10.19.17584.
83. Pisa, M. 1988. Motor functions of the striatum in the rat: critical role of the lateral region in tongue and forelimb reaching. Neuroscience 24 (2) (February): 453-463.
84. Pisa, M, and J Cyr. 1990. Regionally selective roles of the rat's striatum in modality-specific discrimination learning and forelimb reaching. Behavioural Brain Research 37 (3) (March 26): 281-292.
85. Poitras, L, N Ghanem, G Hatch, and M Ekker. 2007. The proneural determinant MASH1 regulates forebrain Dlx1/2 expression through the I12b intergenic enhancer. Development (Cambridge, England) 134 (9) (May): 1755-1765. doi:10.1242/dev.02845.
86. Ramaswamy, S, J L McBride, and J H Kordower. 2007. Animal models of Huntington's disease. ILAR Journal / National Research Council, Institute of Laboratory Animal Resources 48 (4): 356-373.
87. Roitberg, B Z, M E Emborg, J G Sramek, S Palfi, and J H Kordower. 2002. Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease. Neurosurgery 50 (1) (January): 137-145; discussion 145-146.
88. Ross, C A, and S J Tabrizi. 2011. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurology 10 (1) (January): 83-98. doi:10.1016/S1474-4422(10)70245-3.
89. Rosser, A E, R A Barker, T Harrower, C Watts, M Farrington, A K Ho, R M Burnstein, et al. 2002. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. Journal of Neurology, Neurosurgery, and Psychiatry 73 (6) (December): 678-685.
90. Sanberg, P R, M A Henault, and A W Deckel. 1986. Locomotor hyperactivity: effects of multiple striatal transplants in an animal model of Huntington's disease. Pharmacology, Biochemistry, and Behavior 25 (1) (July): 297-300.
91. Schwarcz, R, A C Foster, E D French, W O Whetsell, and C Köhler. 1984. Excitotoxic models for neurodegenerative disorders. Life Sciences 35 (1) (July 2): 19-32.
92. Schwarcz, R, K Fuxe, T Hökfelt, L Terenius, and M Goldstein. 1980. Effects of chronic striatal kainate lesions on some dopaminergic parameters and enkephalin immunoreactive neurons in the basal ganglia. Journal of Neurochemistry 34 (4) (April): 772-778.
93. Schwarcz, R, T Hökfelt, K Fuxe, G Jonsson, M Goldstein, and L Terenius. 1979. Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Experimental Brain Research. Experimentelle Hirnforschung. Expérimentation Cérébrale 37 (2) (October): 199-216.
94. Schwarcz, R, W O Whetsell, and R M Mangano. 1983. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science (New York, N.Y.) 219 (4582) (January 21): 316-318.
95. Shimamura, K, and J L Rubenstein. 1997. Inductive interactions direct early regionalization of the mouse forebrain. Development (Cambridge, England) 124 (14) (July): 2709-2718.
96. Sirinathsinghji, D J, S B Dunnett, O Isacson, D J Clarke, K Kendrick, and A Björklund. 1988. Striatal grafts in rats with unilateral neostriatal lesions--II. In vivo monitoring of GABA release in globus pallidus and substantia nigra. Neuroscience 24 (3) (March): 803-811.
97. Sramka, M, M Rattaj, H Molina, J Vojtassák, V Belan, and E Ruzický. 1992. Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea. Stereotactic and Functional Neurosurgery 58 (1-4): 79-83.
98. Stenevi, U, A Björklund, and N A Svendgaard. 1976. Transplantation of central and peripheral monoamine neurons to the adult rat brain: techniques and conditions for survival. Brain Research 114 (1) (September 10): 1-20.
99. Tepper, J M, and J Paul Bolam. 2004. Functional diversity and specificity of neostriatal interneurons. Current Opinion in Neurobiology 14 (6) (December): 685-692. doi:10.1016/j.conb.2004.10.003.
100. The Huntington's Disease Collaborative Research Group. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (6) (March 26): 971-983.
101. Tymianski, M, M P Charlton, P L Carlen, and C H Tator. 1993. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 13 (5) (May): 2085-2104.
102. Ungerstedt, U. 1971. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiologica Scandinavica. Supplementum 367: 49-68.
103. Vierbuchen, T, A Ostermeier, Z P Pang, Y Kokubu, T C Südhof, and M Wernig. 2010. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463 (7284) (February 25): 1035-1041. doi:10.1038/nature08797.
104. Wang, L H, and Z H Qin. 2006. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies. Acta Pharmacologica Sinica 27 (10) (October): 1287-1302. doi:10.1111/j.1745-7254.2006.00410.x.
105. Whishaw, I Q, G Mittleman, S T Bunch, and S B Dunnett. 1987. Impairments in the acquisition, retention and selection of spatial navigation strategies after medial caudate-putamen lesions in rats. Behavioural Brain Research 24 (2) (May): 125-138.
106. Wictorin, K, P Brundin, H Sauer, O Lindvall, and A Björklund. 1992. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. The Journal of Comparative Neurology 323 (4) (September 22): 475-494. doi:10.1002/cne.903230403.
107. Wijeyekoon, R, and R A Barker. 2011. The Current Status of Neural Grafting in the Treatment of Huntington's Disease. A Review. Frontiers in Integrative Neuroscience 5: 78. doi:10.3389/fnint.2011.00078.
108. Zhang, N, M C An, D Montoro, and L M Ellerby. 2010. Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells. PLoS Currents 2: RRN1193. doi:10.1371/currents.RRN1193.
109. Zietlow, R, E L Lane, S B Dunnett, and A E Rosser. 2008. Human stem cells for CNS repair. Cell and Tissue Research 331 (1) (January): 301-322. doi:10.1007/s00441-007-0488-1.
110. Zuccato, C, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, et al. 2001. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science (New York, N.Y.) 293 (5529) (July 20): 493-498. doi:10.1126/science.1059581.